solifenacin


Also found in: Medical, Wikipedia.
Related to solifenacin: Solifenacin succinate
Translations

solifenacin

n solifenacina
References in periodicals archive ?
Solifenacin did cause embryo toxicity in pregnant mice.
Objective: To analyze the clinical effect of tamsulosin and Solifenacin in the treatment of benign prostatic hyperplasia in combination with overactive bladder and its safety.
Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
The NEPTUNE II study demonstrated a good tolerance and efficacy of long-term treatment with solifenacin plus tamsulosin in men with storage and voiding symptoms, with a low incidence of AUR.
For men with no problems emptying their bladder, anticholinergic medications--examples include oxybutynin (Ditropan[R]), solifenacin (Vesicare[R]) and tolterodine (Detrol[R])--decrease the strength of bladder contractions to help reduce urinary urgency, frequency, and nighttime urination.
The study shows it is possible to boost myelination by targeting human oligodendrocyte progenitor cells with solifenacin, an anti-muscarinic drug that currently is approved and marketed to treat overactive bladder.
To do that, the researchers turned to solifenacin, the anti-muscarinic drug for overactive bladder; the bladder muscle contains several muscarinic receptors.
Efficacy and safety of solifenacin plus tamsulosin oral controlled absorption system in men with lower urinary tract symptoms: a metaanalysis.
Some drugs to watch out for include the following (and their generics): diphenhydramine (Benadryl); certain antidepressants, such as amitriptyline; some diuretics and other drugs for high blood pressure, including losartan (Cozaar) and valsartan (Diovan); and drugs for an overactive bladder, such as oxybutynin (Ditropan), solifenacin (VESIcare) and trospium (Sanctura).
Furthermore, new-generation anticholinergic agents, such as darifenacin and solifenacin, are selective for the M3 receptor and thus offer the potential of reduced side-effects.
Newer anticholinergics approved for treatment of OAB include solifenacin (VESIcare[R]), darifenacin (Enablex[R]), and fesoteradine fumarate (Toviaz[R]) (Nabili, 2013).